Fortis Healthcare Receives Revised Offer From Manipal Healthcare
Fortis Healthcare Ltd, the country's second-largest hospital chain operator headquartered in Delhi, said on Sunday that it has received revised offer from TPG-backed Manipal Health Enterprises Pvt. Ltd.
In its latest offer Manipal will infuse Rs 2,100 crore by subscribing to equity shares of the company at Rs 160 per share.
Key highlights of new offer by Manipal:
- TPG-backed Manipal proposes to merge into Fortis that will value the latter at Rs 8,358 crore translating into Rs 160 rupees a share.
- The offer values Manipal at Rs 6,070 crore, according to a letter dated May 6 from Manipal to the Fortis board, attached to the filing.
- Manipal offers to subscribe to Rs 2,100 crore of shares of Fortis via a preferential allotment at Rs 160 apiece; proceeds to be used by Fortis to repay existing loans, meet working capital requirements and partly fund acquisition of assets from RHT.
- Manipal to buy stake in SRL Ltd. held by private equity firms at a price that values the subsidiary at Rs 3,600 crore.
- After the merger, Fortis will undertake a rights issue to raise additional capital.
- Purchase of RHT assets will also be funded through debt.
- Manipal says new offer doesn't require any further due diligence; proposal is binding and valid until May 15.
Last week, Hero Enterprise Investment Office and the Burman Family Office hiked its joint proposal to invest Rs 1,800 crore directly in Fortis Healthcare. That bid proposes to invest Rs 800 crore by allotment of equity shares through a preferential issue at Rs 167 per share or as per SEBI Issue of Capital and Disclosure Requirements guidelines, whichever is higher, Fortis Healthcare said in a BSE filing.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.